Gene Symbol | Gene ID | Gene Info |
---|---|---|
AIRE
|
ENSG00000160224.12 | autoimmune regulator |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr21_45705593_45705882 | AIRE | 26 | 0.954131 | 0.31 | 4.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_9882638_9884014 | 0.71 |
CLSTN1 |
calsyntenin 1 |
716 |
0.65 |
chr6_154726112_154726296 | 0.59 |
CNKSR3 |
CNKSR family member 3 |
25425 |
0.23 |
chr8_54817773_54817967 | 0.57 |
ENSG00000200528 |
. |
9409 |
0.19 |
chr4_470311_470489 | 0.57 |
ZNF721 |
zinc finger protein 721 |
2444 |
0.24 |
chr7_120630679_120630951 | 0.57 |
CPED1 |
cadherin-like and PC-esterase domain containing 1 |
1139 |
0.51 |
chr14_45711437_45711895 | 0.57 |
MIS18BP1 |
MIS18 binding protein 1 |
10714 |
0.2 |
chr14_100260181_100260448 | 0.55 |
EML1 |
echinoderm microtubule associated protein like 1 |
542 |
0.83 |
chr1_217263352_217263815 | 0.53 |
ESRRG |
estrogen-related receptor gamma |
607 |
0.86 |
chr2_202901871_202902113 | 0.52 |
FZD7 |
frizzled family receptor 7 |
2682 |
0.25 |
chr12_50748152_50748528 | 0.52 |
FAM186A |
family with sequence similarity 186, member A |
3672 |
0.22 |
chr1_172113664_172113837 | 0.51 |
ENSG00000208024 |
. |
34 |
0.69 |
chr5_121412020_121412268 | 0.51 |
LOX |
lysyl oxidase |
1836 |
0.4 |
chr3_15369209_15369360 | 0.51 |
SH3BP5 |
SH3-domain binding protein 5 (BTK-associated) |
4783 |
0.16 |
chr8_116675050_116675578 | 0.51 |
TRPS1 |
trichorhinophalangeal syndrome I |
1409 |
0.6 |
chr20_50664340_50664598 | 0.51 |
ZFP64 |
ZFP64 zinc finger protein |
50536 |
0.17 |
chr21_17443239_17443390 | 0.51 |
ENSG00000252273 |
. |
35485 |
0.23 |
chr2_150903026_150903295 | 0.50 |
ENSG00000207270 |
. |
435872 |
0.01 |
chr12_7037386_7038830 | 0.49 |
ATN1 |
atrophin 1 |
632 |
0.41 |
chr9_102829140_102829291 | 0.49 |
ERP44 |
endoplasmic reticulum protein 44 |
32107 |
0.16 |
chr8_104384541_104384884 | 0.48 |
CTHRC1 |
collagen triple helix repeat containing 1 |
51 |
0.97 |
chr19_34359259_34359976 | 0.47 |
ENSG00000240626 |
. |
58913 |
0.13 |
chr1_243415347_243415602 | 0.46 |
CEP170 |
centrosomal protein 170kDa |
1148 |
0.47 |
chr5_14443711_14444058 | 0.46 |
TRIO |
trio Rho guanine nucleotide exchange factor |
44673 |
0.2 |
chrX_14882707_14882858 | 0.45 |
FANCB |
Fanconi anemia, complementation group B |
8392 |
0.24 |
chr6_151392247_151392482 | 0.45 |
RP1-292B18.3 |
|
15171 |
0.18 |
chr14_51387153_51387346 | 0.45 |
RP11-218E20.5 |
|
8305 |
0.17 |
chr15_78594347_78594498 | 0.45 |
WDR61 |
WD repeat domain 61 |
2286 |
0.2 |
chr13_24146543_24146694 | 0.45 |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
1815 |
0.49 |
chrX_114467670_114468385 | 0.45 |
LRCH2 |
leucine-rich repeats and calponin homology (CH) domain containing 2 |
601 |
0.77 |
chr3_173302379_173302636 | 0.44 |
NLGN1 |
neuroligin 1 |
162 |
0.98 |
chr19_11306068_11306280 | 0.44 |
KANK2 |
KN motif and ankyrin repeat domains 2 |
187 |
0.9 |
chr1_98514742_98514981 | 0.44 |
ENSG00000225206 |
. |
3134 |
0.4 |
chr16_15588070_15588221 | 0.43 |
C16orf45 |
chromosome 16 open reading frame 45 |
7978 |
0.23 |
chr9_130615060_130615211 | 0.43 |
ENG |
endoglin |
1780 |
0.16 |
chr12_42978890_42979099 | 0.43 |
PRICKLE1 |
prickle homolog 1 (Drosophila) |
4484 |
0.31 |
chr8_9413349_9414633 | 0.43 |
RP11-375N15.2 |
|
39 |
0.92 |
chr3_11651207_11651493 | 0.42 |
VGLL4 |
vestigial like 4 (Drosophila) |
628 |
0.65 |
chr10_26846446_26846738 | 0.42 |
ENSG00000199733 |
. |
48074 |
0.17 |
chrX_54947220_54948504 | 0.42 |
TRO |
trophinin |
41 |
0.97 |
chr11_63438034_63439177 | 0.42 |
ATL3 |
atlastin GTPase 3 |
479 |
0.76 |
chr2_38265076_38265999 | 0.42 |
RMDN2-AS1 |
RMDN2 antisense RNA 1 |
2053 |
0.33 |
chr9_97666762_97667035 | 0.42 |
RP11-49O14.2 |
|
4187 |
0.23 |
chr3_79066759_79066910 | 0.42 |
ROBO1 |
roundabout, axon guidance receptor, homolog 1 (Drosophila) |
860 |
0.75 |
chr15_86194014_86194165 | 0.42 |
ENSG00000202081 |
. |
770 |
0.54 |
chr11_114167265_114167463 | 0.42 |
NNMT |
nicotinamide N-methyltransferase |
721 |
0.72 |
chr16_10679196_10679376 | 0.42 |
EMP2 |
epithelial membrane protein 2 |
4731 |
0.2 |
chr18_43785173_43785324 | 0.41 |
C18orf25 |
chromosome 18 open reading frame 25 |
31248 |
0.18 |
chr8_142048186_142048475 | 0.41 |
PTK2 |
protein tyrosine kinase 2 |
36121 |
0.17 |
chr3_32728169_32728353 | 0.41 |
CNOT10 |
CCR4-NOT transcription complex, subunit 10 |
1405 |
0.51 |
chr15_95870278_95870659 | 0.41 |
ENSG00000222076 |
. |
418565 |
0.01 |
chr5_72733592_72733937 | 0.41 |
FOXD1 |
forkhead box D1 |
10588 |
0.21 |
chr10_65275500_65275740 | 0.41 |
REEP3 |
receptor accessory protein 3 |
5503 |
0.26 |
chr1_163039219_163039545 | 0.41 |
RGS4 |
regulator of G-protein signaling 4 |
231 |
0.96 |
chr4_175750179_175750687 | 0.41 |
GLRA3 |
glycine receptor, alpha 3 |
32 |
0.99 |
chr11_108766543_108766821 | 0.41 |
ENSG00000201243 |
. |
109562 |
0.07 |
chr12_12111873_12112098 | 0.41 |
ETV6 |
ets variant 6 |
73114 |
0.11 |
chr21_22548095_22548278 | 0.40 |
NCAM2 |
neural cell adhesion molecule 2 |
28748 |
0.23 |
chr14_73881950_73882101 | 0.40 |
NUMB |
numb homolog (Drosophila) |
5246 |
0.21 |
chr11_56981115_56981363 | 0.40 |
APLNR |
apelin receptor |
23436 |
0.16 |
chr15_96880068_96880219 | 0.40 |
ENSG00000222651 |
. |
3653 |
0.19 |
chr5_89317042_89317197 | 0.40 |
ENSG00000264342 |
. |
4582 |
0.37 |
chr4_74763571_74763722 | 0.40 |
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
28525 |
0.13 |
chr2_151424342_151424493 | 0.40 |
RND3 |
Rho family GTPase 3 |
28892 |
0.27 |
chr8_77596544_77596695 | 0.40 |
ZFHX4 |
zinc finger homeobox 4 |
603 |
0.65 |
chr2_47571438_47571633 | 0.40 |
EPCAM |
epithelial cell adhesion molecule |
762 |
0.64 |
chr7_70159815_70160908 | 0.39 |
AUTS2 |
autism susceptibility candidate 2 |
33764 |
0.25 |
chr10_74591963_74592114 | 0.39 |
OIT3 |
oncoprotein induced transcript 3 |
61301 |
0.1 |
chr8_136975571_136975722 | 0.39 |
ENSG00000199652 |
. |
220908 |
0.02 |
chr10_95136415_95136839 | 0.39 |
MYOF |
myoferlin |
105324 |
0.06 |
chr9_109622995_109623671 | 0.39 |
ZNF462 |
zinc finger protein 462 |
2045 |
0.37 |
chr1_199824347_199824498 | 0.38 |
ENSG00000200139 |
. |
32865 |
0.22 |
chr4_71570546_71572213 | 0.38 |
RUFY3 |
RUN and FYVE domain containing 3 |
861 |
0.36 |
chr4_41215270_41215769 | 0.38 |
APBB2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
956 |
0.59 |
chr1_157013915_157014350 | 0.38 |
ARHGEF11 |
Rho guanine nucleotide exchange factor (GEF) 11 |
733 |
0.68 |
chr2_86225315_86225466 | 0.38 |
POLR1A |
polymerase (RNA) I polypeptide A, 194kDa |
107888 |
0.05 |
chr2_198539523_198539712 | 0.38 |
RFTN2 |
raftlin family member 2 |
1102 |
0.51 |
chr4_116139793_116139944 | 0.38 |
NDST4 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 4 |
104836 |
0.08 |
chr8_107904204_107904364 | 0.38 |
ABRA |
actin-binding Rho activating protein |
121811 |
0.06 |
chr5_127981549_127981700 | 0.37 |
FBN2 |
fibrillin 2 |
13254 |
0.23 |
chr7_127318860_127319011 | 0.37 |
SND1 |
staphylococcal nuclease and tudor domain containing 1 |
26701 |
0.16 |
chr12_78334931_78335200 | 0.37 |
NAV3 |
neuron navigator 3 |
24991 |
0.28 |
chr9_16680814_16680965 | 0.37 |
BNC2 |
basonuclin 2 |
24191 |
0.21 |
chr13_37492943_37493377 | 0.37 |
SMAD9 |
SMAD family member 9 |
1215 |
0.52 |
chr1_192757431_192757794 | 0.37 |
RGS2 |
regulator of G-protein signaling 2, 24kDa |
20559 |
0.24 |
chr2_38299955_38300348 | 0.37 |
CYP1B1-AS1 |
CYP1B1 antisense RNA 1 |
2640 |
0.23 |
chr7_93552303_93552503 | 0.37 |
GNG11 |
guanine nucleotide binding protein (G protein), gamma 11 |
1392 |
0.38 |
chr18_56121962_56122204 | 0.37 |
ENSG00000207778 |
. |
3777 |
0.21 |
chr12_109079040_109079191 | 0.36 |
CORO1C |
coronin, actin binding protein, 1C |
11063 |
0.15 |
chr6_162052900_162053180 | 0.36 |
ENSG00000221021 |
. |
16942 |
0.31 |
chr6_76645073_76645368 | 0.36 |
IMPG1 |
interphotoreceptor matrix proteoglycan 1 |
454 |
0.81 |
chr6_151392500_151392798 | 0.36 |
RP1-292B18.3 |
|
15456 |
0.18 |
chr7_116141197_116141631 | 0.36 |
CAV2 |
caveolin 2 |
1580 |
0.29 |
chr10_60198379_60198605 | 0.36 |
TFAM |
transcription factor A, mitochondrial |
53128 |
0.15 |
chr12_59398105_59398256 | 0.36 |
RP11-150C16.1 |
|
83760 |
0.1 |
chr22_46473276_46473626 | 0.36 |
FLJ27365 |
hsa-mir-4763 |
2741 |
0.14 |
chr4_77508066_77508217 | 0.35 |
ENSG00000265314 |
. |
11437 |
0.17 |
chr3_75833792_75835020 | 0.35 |
ZNF717 |
zinc finger protein 717 |
151 |
0.97 |
chr6_16850081_16850303 | 0.35 |
RP1-151F17.1 |
|
88049 |
0.09 |
chr3_65744862_65745013 | 0.35 |
MAGI1-AS1 |
MAGI1 antisense RNA 1 |
134554 |
0.05 |
chr4_146855718_146855869 | 0.35 |
ZNF827 |
zinc finger protein 827 |
3830 |
0.28 |
chr3_32001250_32001418 | 0.35 |
OSBPL10 |
oxysterol binding protein-like 10 |
21458 |
0.18 |
chr6_57296683_57296834 | 0.35 |
ENSG00000212017 |
. |
41828 |
0.2 |
chr12_59312115_59312531 | 0.35 |
LRIG3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
1004 |
0.56 |
chr4_169614920_169615071 | 0.35 |
ENSG00000206613 |
. |
7128 |
0.22 |
chr9_36277071_36277282 | 0.35 |
GNE |
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
123 |
0.97 |
chr11_122037044_122037237 | 0.35 |
ENSG00000207994 |
. |
14124 |
0.17 |
chr15_96889520_96889695 | 0.35 |
ENSG00000222651 |
. |
13117 |
0.15 |
chr15_44196245_44196396 | 0.35 |
FRMD5 |
FERM domain containing 5 |
15380 |
0.15 |
chr7_22646904_22647055 | 0.35 |
AC002480.4 |
|
17655 |
0.17 |
chr9_126331371_126331654 | 0.35 |
ENSG00000222722 |
. |
16224 |
0.24 |
chr5_98113295_98113446 | 0.34 |
RGMB |
repulsive guidance molecule family member b |
4031 |
0.25 |
chr2_191748635_191749149 | 0.34 |
AC005540.3 |
|
2107 |
0.33 |
chr1_60204181_60204332 | 0.34 |
ENSG00000266150 |
. |
5288 |
0.28 |
chr6_83900430_83900634 | 0.34 |
PGM3 |
phosphoglucomutase 3 |
2168 |
0.3 |
chr2_192500334_192500574 | 0.34 |
NABP1 |
nucleic acid binding protein 1 |
42408 |
0.2 |
chr7_24972774_24972925 | 0.34 |
OSBPL3 |
oxysterol binding protein-like 3 |
15137 |
0.24 |
chr14_52925377_52925528 | 0.34 |
TXNDC16 |
thioredoxin domain containing 16 |
93771 |
0.07 |
chr1_114403266_114403417 | 0.34 |
AP4B1-AS1 |
AP4B1 antisense RNA 1 |
4084 |
0.15 |
chr13_74637272_74637666 | 0.34 |
KLF12 |
Kruppel-like factor 12 |
68283 |
0.14 |
chr7_27217405_27217623 | 0.34 |
RP1-170O19.20 |
Uncharacterized protein |
2118 |
0.1 |
chr5_111110911_111111062 | 0.34 |
NREP |
neuronal regeneration related protein |
17071 |
0.21 |
chr5_155903124_155903466 | 0.34 |
SGCD |
sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) |
149528 |
0.04 |
chr10_78924352_78924699 | 0.34 |
RP11-180I22.2 |
|
16475 |
0.25 |
chr19_58689540_58689691 | 0.34 |
ZNF274 |
zinc finger protein 274 |
4781 |
0.15 |
chr2_5835221_5835372 | 0.34 |
SOX11 |
SRY (sex determining region Y)-box 11 |
2497 |
0.27 |
chr13_45146605_45146867 | 0.34 |
TSC22D1 |
TSC22 domain family, member 1 |
3656 |
0.33 |
chr1_162603392_162603656 | 0.34 |
DDR2 |
discoidin domain receptor tyrosine kinase 2 |
1264 |
0.48 |
chr1_35688354_35688505 | 0.34 |
ENSG00000201868 |
. |
26859 |
0.13 |
chr2_166430308_166430713 | 0.34 |
CSRNP3 |
cysteine-serine-rich nuclear protein 3 |
109 |
0.98 |
chr8_18578408_18578634 | 0.34 |
RP11-161I2.1 |
|
106 |
0.98 |
chr7_5673628_5673882 | 0.34 |
FSCN1 |
fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) |
39438 |
0.12 |
chr13_33684806_33685110 | 0.34 |
STARD13-IT1 |
STARD13 intronic transcript 1 (non-protein coding) |
53588 |
0.13 |
chr6_149256072_149256223 | 0.34 |
RP11-162J8.2 |
|
29673 |
0.23 |
chr8_6539493_6539644 | 0.34 |
CTD-2541M15.1 |
|
26132 |
0.18 |
chr1_170640402_170640573 | 0.34 |
PRRX1 |
paired related homeobox 1 |
7409 |
0.3 |
chr21_17442706_17442989 | 0.34 |
ENSG00000252273 |
. |
35018 |
0.24 |
chr6_3910498_3910912 | 0.33 |
FAM50B |
family with sequence similarity 50, member B |
61083 |
0.1 |
chr9_12859535_12860149 | 0.33 |
ENSG00000222658 |
. |
25478 |
0.2 |
chr9_114061539_114061711 | 0.33 |
OR2K2 |
olfactory receptor, family 2, subfamily K, member 2 |
29088 |
0.21 |
chr3_15598382_15598533 | 0.33 |
COLQ |
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
35199 |
0.11 |
chr1_203482311_203482608 | 0.33 |
OPTC |
opticin |
17361 |
0.21 |
chr21_17584847_17584998 | 0.33 |
ENSG00000201025 |
. |
72167 |
0.13 |
chr7_134464463_134465343 | 0.33 |
CALD1 |
caldesmon 1 |
474 |
0.89 |
chr8_128938937_128939156 | 0.33 |
TMEM75 |
transmembrane protein 75 |
21545 |
0.19 |
chr4_169553568_169553728 | 0.33 |
PALLD |
palladin, cytoskeletal associated protein |
880 |
0.63 |
chr7_19437447_19437598 | 0.33 |
FERD3L |
Fer3-like bHLH transcription factor |
252478 |
0.02 |
chr1_23066485_23066803 | 0.33 |
ENSG00000216157 |
. |
8760 |
0.17 |
chr4_110223153_110224430 | 0.33 |
COL25A1 |
collagen, type XXV, alpha 1 |
8 |
0.99 |
chr10_77157105_77157688 | 0.33 |
ENSG00000237149 |
. |
3881 |
0.22 |
chr7_27191312_27191528 | 0.33 |
HOXA-AS3 |
HOXA cluster antisense RNA 3 |
1749 |
0.13 |
chr21_28336747_28336898 | 0.33 |
ADAMTS5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
2010 |
0.38 |
chr12_62998637_62998788 | 0.33 |
ENSG00000199179 |
. |
1246 |
0.3 |
chr12_3001234_3001385 | 0.33 |
TULP3 |
tubby like protein 3 |
1236 |
0.31 |
chr6_28109319_28110552 | 0.33 |
ZKSCAN8 |
zinc finger with KRAB and SCAN domains 8 |
219 |
0.89 |
chr14_75515800_75515951 | 0.33 |
MLH3 |
mutL homolog 3 |
519 |
0.68 |
chr1_214551590_214551850 | 0.33 |
RP11-176D17.3 |
|
20762 |
0.23 |
chr2_161826657_161826810 | 0.33 |
ENSG00000244372 |
. |
92675 |
0.09 |
chr2_210390985_210391683 | 0.32 |
MAP2 |
microtubule-associated protein 2 |
52705 |
0.18 |
chr17_65208623_65208774 | 0.32 |
RP11-401F2.4 |
|
11721 |
0.16 |
chr11_35035790_35035960 | 0.32 |
PDHX |
pyruvate dehydrogenase complex, component X |
36544 |
0.17 |
chr9_128235766_128235975 | 0.32 |
MAPKAP1 |
mitogen-activated protein kinase associated protein 1 |
10910 |
0.23 |
chr2_188353955_188354194 | 0.32 |
TFPI |
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
24294 |
0.21 |
chr19_56578206_56578448 | 0.32 |
ZNF787 |
zinc finger protein 787 |
36526 |
0.11 |
chr14_78073975_78074126 | 0.32 |
SPTLC2 |
serine palmitoyltransferase, long chain base subunit 2 |
9066 |
0.2 |
chr5_3597777_3597928 | 0.32 |
IRX1 |
iroquois homeobox 1 |
1684 |
0.41 |
chr7_67383536_67383687 | 0.32 |
ENSG00000265600 |
. |
561944 |
0.0 |
chr12_2162213_2162837 | 0.32 |
CACNA1C |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
61 |
0.97 |
chr4_140926197_140926348 | 0.32 |
MAML3 |
mastermind-like 3 (Drosophila) |
114151 |
0.06 |
chrX_34673939_34674563 | 0.32 |
TMEM47 |
transmembrane protein 47 |
1154 |
0.68 |
chr1_78472118_78472672 | 0.32 |
DNAJB4 |
DnaJ (Hsp40) homolog, subfamily B, member 4 |
1857 |
0.26 |
chr1_205168795_205169031 | 0.32 |
DSTYK |
dual serine/threonine and tyrosine protein kinase |
11781 |
0.17 |
chr2_216294640_216294791 | 0.32 |
FN1 |
fibronectin 1 |
6075 |
0.23 |
chr17_27720697_27720848 | 0.32 |
TAOK1 |
TAO kinase 1 |
2823 |
0.15 |
chr15_77750021_77750172 | 0.32 |
HMG20A |
high mobility group 20A |
463 |
0.87 |
chr11_31005768_31005986 | 0.32 |
DCDC1 |
doublecortin domain containing 1 |
8356 |
0.32 |
chr16_55513844_55514378 | 0.31 |
MMP2 |
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
201 |
0.95 |
chr1_103571993_103572213 | 0.31 |
COL11A1 |
collagen, type XI, alpha 1 |
1631 |
0.56 |
chr21_42662684_42662835 | 0.31 |
FAM3B |
family with sequence similarity 3, member B |
25902 |
0.18 |
chr17_45982661_45983102 | 0.31 |
SP2 |
Sp2 transcription factor |
9365 |
0.1 |
chr2_45679896_45680047 | 0.31 |
SRBD1 |
S1 RNA binding domain 1 |
115183 |
0.06 |
chr4_187901481_187901677 | 0.31 |
ENSG00000252382 |
. |
122969 |
0.06 |
chr12_15490173_15490332 | 0.31 |
RERG |
RAS-like, estrogen-regulated, growth inhibitor |
11280 |
0.23 |
chr7_116168289_116168733 | 0.31 |
CAV1 |
caveolin 1, caveolae protein, 22kDa |
2164 |
0.26 |
chr5_141700452_141700811 | 0.31 |
SPRY4 |
sprouty homolog 4 (Drosophila) |
3116 |
0.28 |
chr7_134465998_134466492 | 0.31 |
CALD1 |
caldesmon 1 |
1816 |
0.49 |
chr13_102050945_102051096 | 0.31 |
NALCN |
sodium leak channel, non-selective |
485 |
0.88 |
chr7_82072002_82072462 | 0.31 |
CACNA2D1 |
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
799 |
0.78 |
chr2_208122869_208123109 | 0.31 |
AC007879.5 |
|
4013 |
0.26 |
chr12_117037726_117037963 | 0.31 |
MAP1LC3B2 |
microtubule-associated protein 1 light chain 3 beta 2 |
24188 |
0.24 |
chr3_25470884_25471099 | 0.31 |
RARB |
retinoic acid receptor, beta |
1189 |
0.61 |
chr5_125960121_125960311 | 0.31 |
C5orf48 |
chromosome 5 open reading frame 48 |
7198 |
0.19 |
chr3_285704_285855 | 0.31 |
CHL1 |
cell adhesion molecule L1-like |
26561 |
0.19 |
chr20_10340480_10340631 | 0.31 |
ENSG00000211588 |
. |
2323 |
0.32 |
chr9_101803305_101803593 | 0.31 |
TGFBR1 |
transforming growth factor, beta receptor 1 |
62871 |
0.11 |
chr6_19691587_19692480 | 0.31 |
ENSG00000200957 |
. |
49273 |
0.18 |
chr2_200310339_200310490 | 0.31 |
SATB2 |
SATB homeobox 2 |
10397 |
0.24 |
chr17_60868253_60868692 | 0.31 |
MARCH10 |
membrane-associated ring finger (C3HC4) 10, E3 ubiquitin protein ligase |
15529 |
0.23 |
chr19_55684291_55685412 | 0.31 |
SYT5 |
synaptotagmin V |
1083 |
0.28 |
chr4_61549406_61549584 | 0.31 |
ENSG00000216027 |
. |
19739 |
0.3 |
chr4_162635469_162635763 | 0.31 |
RP11-497K21.1 |
|
308269 |
0.01 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.8 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.2 | 0.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.6 | GO:0071692 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.2 | 0.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 0.5 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 0.5 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 0.5 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.4 | GO:0008049 | male courtship behavior(GO:0008049) |
0.1 | 0.4 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.4 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.6 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 0.6 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 0.3 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 | 0.6 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 0.4 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.3 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.7 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.1 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.1 | 0.4 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.1 | 0.4 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.7 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.1 | 0.4 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 0.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.5 | GO:1903020 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.1 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.3 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 1.8 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.2 | GO:0031223 | response to auditory stimulus(GO:0010996) auditory behavior(GO:0031223) |
0.1 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.1 | GO:1903053 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.2 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.4 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.1 | 0.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.1 | GO:0072070 | loop of Henle development(GO:0072070) |
0.1 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.1 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.1 | 0.3 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.4 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.1 | 0.3 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.3 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.1 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.1 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.2 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 0.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.1 | GO:0072189 | positive regulation of smooth muscle cell differentiation(GO:0051152) ureter development(GO:0072189) kidney smooth muscle tissue development(GO:0072194) |
0.1 | 0.1 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.4 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.5 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.1 | 0.2 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) |
0.1 | 0.2 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.4 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.1 | 0.4 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.1 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.1 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.1 | 0.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.2 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.1 | 0.1 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.2 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.2 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.2 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.3 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.3 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.0 | 0.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.3 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.1 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.0 | 0.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.3 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.2 | GO:0009188 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.0 | 0.1 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.0 | 0.1 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.0 | 0.1 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.0 | 0.1 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.0 | 0.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.1 | GO:0060391 | regulation of SMAD protein import into nucleus(GO:0060390) positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.0 | 0.2 | GO:0045920 | negative regulation of exocytosis(GO:0045920) |
0.0 | 0.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.0 | 0.3 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0060900 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) embryonic camera-type eye formation(GO:0060900) |
0.0 | 0.1 | GO:0010587 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.0 | 0.1 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.0 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.0 | 0.1 | GO:0032730 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.0 | 0.2 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.2 | GO:0051307 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.0 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.3 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.1 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 0.5 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.1 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.5 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.2 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.2 | GO:0003281 | ventricular septum development(GO:0003281) |
0.0 | 0.1 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.3 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 0.2 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.3 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.1 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.0 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.1 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.0 | 0.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.0 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.0 | 0.1 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.0 | 0.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.4 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.6 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.6 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.2 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.1 | GO:0002686 | negative regulation of leukocyte migration(GO:0002686) |
0.0 | 0.1 | GO:2000794 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.0 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.1 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.0 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.0 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.1 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.0 | 0.1 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.0 | 0.1 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.2 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.0 | GO:0060068 | vagina development(GO:0060068) |
0.0 | 0.1 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.0 | 0.1 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.0 | 0.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.0 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.1 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.0 | 0.1 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.0 | 0.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.1 | GO:0060087 | relaxation of smooth muscle(GO:0044557) negative regulation of smooth muscle contraction(GO:0045986) relaxation of vascular smooth muscle(GO:0060087) |
0.0 | 0.0 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.3 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.1 | GO:0051597 | response to methylmercury(GO:0051597) |
0.0 | 0.1 | GO:0060347 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.0 | 0.1 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.0 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.1 | GO:0006533 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.0 | 0.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.2 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.2 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.0 | 0.1 | GO:0034331 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.0 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.2 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.0 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.0 | 0.2 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.0 | 0.0 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.1 | GO:0070091 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.0 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.5 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.3 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.1 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.1 | GO:0030033 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.0 | 0.2 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.0 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.1 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.0 | 0.2 | GO:0045844 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:0021754 | facial nucleus development(GO:0021754) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.1 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.0 | 1.1 | GO:0030198 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.0 | 0.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.2 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.6 | GO:0060606 | neural tube closure(GO:0001843) tube closure(GO:0060606) |
0.0 | 0.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.1 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.1 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.0 | 0.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.0 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.0 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.9 | GO:0034332 | adherens junction organization(GO:0034332) |
0.0 | 0.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.2 | GO:0006949 | syncytium formation(GO:0006949) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.0 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.1 | GO:1903523 | negative regulation of heart contraction(GO:0045822) negative regulation of blood circulation(GO:1903523) |
0.0 | 0.1 | GO:0051567 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
0.0 | 0.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.0 | GO:0060174 | limb bud formation(GO:0060174) |
0.0 | 0.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.0 | GO:2000757 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.0 | 0.1 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.0 | GO:0019731 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
0.0 | 0.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.0 | 0.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 0.1 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.0 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.3 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.3 | GO:0001942 | hair follicle development(GO:0001942) molting cycle process(GO:0022404) hair cycle process(GO:0022405) skin epidermis development(GO:0098773) |
0.0 | 0.0 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.0 | GO:0033197 | response to vitamin E(GO:0033197) |
0.0 | 0.1 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.1 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 0.0 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.0 | 0.1 | GO:0043324 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.0 | 0.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.0 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.0 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.0 | GO:0060911 | cardiac cell fate commitment(GO:0060911) |
0.0 | 0.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.0 | 0.1 | GO:0090102 | cochlea development(GO:0090102) |
0.0 | 0.0 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 | 0.1 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.0 | 0.0 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.0 | 0.0 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.2 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.0 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.0 | 0.0 | GO:0043049 | otic placode formation(GO:0043049) |
0.0 | 0.1 | GO:0048935 | peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.4 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.3 | GO:0030010 | establishment of cell polarity(GO:0030010) |
0.0 | 0.0 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.0 | GO:2000756 | regulation of histone acetylation(GO:0035065) regulation of protein acetylation(GO:1901983) regulation of peptidyl-lysine acetylation(GO:2000756) |
0.0 | 0.0 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.0 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.0 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.1 | GO:0009414 | response to water deprivation(GO:0009414) |
0.0 | 0.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.0 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.0 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.1 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.2 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.0 | 1.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.0 | 0.0 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.0 | 0.1 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.0 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.0 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.0 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.0 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.0 | 0.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.0 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.0 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.0 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.0 | 0.0 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.0 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.0 | 0.0 | GO:0000470 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.2 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.0 | 0.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.0 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.1 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.0 | GO:0043247 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.0 | GO:0071801 | regulation of podosome assembly(GO:0071801) positive regulation of podosome assembly(GO:0071803) |
0.0 | 0.0 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.0 | 0.0 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.0 | 0.0 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 0.1 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.0 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.0 | GO:0042723 | vitamin transmembrane transport(GO:0035461) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.0 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.0 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.2 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
0.0 | 0.1 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.0 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.0 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.2 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.0 | 0.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.0 | GO:0060242 | contact inhibition(GO:0060242) |
0.0 | 0.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0008615 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.0 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.2 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.0 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 0.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.2 | 1.2 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.4 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.5 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.1 | 0.4 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.2 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.1 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.0 | 0.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.0 | 0.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 0.1 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.3 | GO:0043034 | costamere(GO:0043034) |
0.0 | 1.0 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.6 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.4 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.6 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.1 | GO:0043205 | fibril(GO:0043205) |
0.0 | 0.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 1.2 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.0 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.0 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.0 | 1.3 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.7 | GO:0044309 | neuron spine(GO:0044309) |
0.0 | 0.2 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.2 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 4.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.1 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.6 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.4 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 1.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.0 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.0 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.0 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.2 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.0 | 0.1 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.1 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.9 | GO:0030016 | myofibril(GO:0030016) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.6 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.2 | 0.5 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 1.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.3 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.4 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 0.2 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 0.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 1.6 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.2 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 0.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 1.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 1.9 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.2 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.2 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.2 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.0 | 0.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.2 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.0 | 0.6 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.1 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.0 | 0.2 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.2 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.1 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.0 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 2.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.0 | 0.1 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.1 | GO:0032558 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.0 | 0.2 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.3 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.5 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.3 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 0.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.3 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 0.4 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.0 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 0.1 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.2 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.2 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.1 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.0 | 0.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.0 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.1 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.1 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.0 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.1 | GO:0001228 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.0 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 0.1 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.1 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.1 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.2 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.0 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.2 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.0 | 0.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.4 | GO:0019199 | transmembrane receptor protein kinase activity(GO:0019199) |
0.0 | 0.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.3 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.0 | 0.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.1 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.0 | 0.0 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.0 | 0.0 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.0 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.1 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.0 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 3.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 1.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 1.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 2.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.3 | PID BMP PATHWAY | BMP receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 1.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.1 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 2.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.0 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.0 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 1.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.0 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.0 | 0.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.4 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.4 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.0 | 0.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.4 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.0 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |